• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, June 25, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Surprising insight into Legionnaires’ disease

Bioengineer by Bioengineer
July 24, 2019
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Frankfurt researchers have explained the mechanism of regulator SidJ in detail — accelerated publication in Nature

IMAGE

Credit: EMBL Grenoble

In order to control cellular processes and thwart the immune system, the bacterium Legionella pneumophilia, the cause of the notorious Legionnaires’ disease, releases hundreds of enzymes. Biochemists at Goethe University have now elucidated important details in the interaction of bacterial effectors. They discovered how the regulatory enzyme SidJ keeps other dangerous virulence factors in check.

The incidence of Legionnaires’ disease has increased in the past two decades. The natural habitat of Legionella is freshwater biotopes, where they mainly reproduce in amoebae. In addition, Legionella can also colonize water tanks or pipes and spread, for example, via poorly maintained air-conditioning systems. Contaminated aerosols are released into the air and trigger the infection. The pathogens cause, among others, pneumonia, which is often fatal in elderly patients or individuals with a weak immune system.

What makes Legionella so dangerous is its ability to multiply in phagocytes of the immune system by secreting virulence factors. Some of these effectors – the enzymes of what is known as the SidE family – are so toxic that without tight control they would instantly kill their host cells. However, since Legionella needs the host cells in order to multiply, it has developed a sophisticated mechanism for the precise metering of SidE enzyme activity. Details of this process are now reported by scientists at Goethe University and from Grenoble in the journal Nature.

They have shown that the regulator SidJ also released by Legionella works as an antidote to SidE enzymes, thus ensuring accurate control of SidE activity. The SidJ regulator is a glutamylase, i.e. it has a rare enzyme activity that allows amino acid glutamates to be linked together to form chains. In this case, SidJ attacks the central glutamate of SidE enzymes and inhibits their activity. So far, little is known about glutamylases – so the scientists were all the more surprised when they discovered that it is precisely this type of enzyme which is important for the coordinated interaction of the virulence factors of Legionella.

“This is a typical example of how completely unpredictable results drive research. Such discoveries are what make science such a fascinating and exciting profession,” says Professor Ivan Dikic from the Institute of Biochemistry II and the Buchmann Institute for Molecular Life Sciences at Goethe University. “We can only gain a molecular understanding of the complex world of bacterial infections by working in interdisciplinary teams and combining methods from modern biochemistry and proteomics with cell and structural biology techniques.”

The researchers also revealed how SidJ is activated in host cells: It requires the calcium-binding protein calmodulin found in mammalian cells. Cryo-electron microscopy played an important role in explaining the structure of the calmodulin-SidJ complex. “Glutamylation as a protein modification is understudied. Our finding that Legionella pneumophilia uses exactly this mechanism to sustain the infection certainly argues for more research in this field. For example, the extent to which Legionella utilizes this modification to regulate other cellular processes is completely unclear,” explains Dr. Sagar Bhogaraju, who led the microscopic examinations at the European Molecular Biology Laboratory (EMBL) in Grenoble.

This so far unknown mechanism opens up new possibilities for research to inhibit the spread of Legionella in the host organism. “We’re currently working on eliminating SidJ selectively by developing inhibitors for the glutamylase domain. In addition to the use of antibiotics, they could prevent the spread of Legionella pneumophilia in phagocytes,” explains Dikic.

###

Media Contact
Ivan Dikic
[email protected]

Related Journal Article

http://dx.doi.org/10.1038/s41586-019-1440-8

Tags: BacteriologyBiochemistryInfectious/Emerging DiseasesMedicine/Health
Share12Tweet8Share2ShareShareShare2

Related Posts

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

June 25, 2026

International Team Including Dresden Scientists Develops Novel Designer Proteins for Advanced Study of Living Tissue

June 25, 2026

New Study Uncovers Key Factors Driving Water Chemistry in Nanoscale Environments

June 25, 2026

Plasma Technology Extends Catalyst Lifespan in Hydrogen Production

June 24, 2026
Please login to join discussion

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracking Lanthanide-Labeled Microplastics in Plants

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.